Guru Fundamental Report for ISRG

Validea's guru fundamental report indicates that Intuitive Surgical (ISRG) receives a 75% rating based on their Multi-Factor Investor model, which is based on the strategy of Pim van Vliet and favors low volatility stocks with strong momentum and high net payout yields; a score of 80% or higher suggests the strategy has interest in the stock. While ISRG passes the market cap and standard deviation tests, it is neutral in terms of twelve minus one momentum and net payout yield, ultimately resulting in a failing final rank according to the model's specific criteria.

Analysis

Intuitive Surgical Inc. (ISRG), a large-cap growth stock in the Medical Equipment & Supplies industry, has been evaluated by Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy favoring low volatility stocks with strong momentum and high net payout yields. ISRG achieved a rating of 75% under this model; while a score above 80% typically indicates model interest, ISRG's score falls short of this threshold. The stock successfully passed the model's criteria for Market Cap and Standard Deviation, indicating favorable characteristics in these areas. However, it received neutral assessments for 'Twelve Minus One Momentum' and 'Net Payout Yield,' signifying these factors are not currently strong positives according to the model. Consequently, despite passing on some metrics, ISRG received a 'FAIL' on its 'FINAL RANK' within this specific strategy. The overall sentiment associated with this report is mixed (-0.15 sentiment score, -0.2 for ISRG specifically), reflecting the nuanced outcome where some fundamental aspects are positive but the stock does not fully align with all key criteria of this particular investment model.

Key Decisions for Investors

• Investors should note that while ISRG exhibits favorable low volatility characteristics, its neutral momentum and net payout yield, leading to a 'FAIL' rank under Validea's Pim van Vliet model, suggest it may not fully align with strategies strictly prioritizing all three factors.
• Further due diligence is warranted on ISRG's momentum and net payout yield to understand if these neutral factors present a significant headwind or if other strengths offset these model-specific concerns.
• Consider this specific model's assessment as one data point among others, particularly as ISRG passed on market cap and standard deviation, indicating some underlying strengths despite not meeting all criteria for this multi-factor strategy.